Ameritas Investment Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5K | Hold |
3,832
| – | – | ﹤0.01% | 2158 |
|
|
2025
Q1 | $42.4K | Hold |
3,832
| – | – | ﹤0.01% | 2204 |
|
|
2024
Q4 | $40.8K | Hold |
3,832
| – | – | ﹤0.01% | 2305 |
|
|
2024
Q3 | $48.7K | Buy |
3,832
+1,016
| +36% | +$12.9K | ﹤0.01% | 2207 |
|
|
2024
Q2 | $47.3K | Hold |
2,816
| – | – | ﹤0.01% | 2167 |
|
|
2024
Q1 | $42.2K | Hold |
2,816
| – | – | ﹤0.01% | 2236 |
|
|
2023
Q4 | $42.2K | Buy |
2,816
+1,200
| +74% | +$18K | ﹤0.01% | 2268 |
|
|
2023
Q3 | $22.6K | Hold |
1,616
| – | – | ﹤0.01% | 2484 |
|
|
2023
Q2 | $16.7K | Buy |
+1,616
| New | +$16.7K | ﹤0.01% | 2651 |
|
|
2022
Q2 | – | Sell |
-1,653
| Closed | -$14K | – | 3239 |
|
|
2022
Q1 | $14K | Hold |
1,653
| – | – | ﹤0.01% | 2692 |
|
|
2021
Q4 | $16K | Hold |
1,653
| – | – | ﹤0.01% | 2742 |
|
|
2021
Q3 | $28K | Hold |
1,653
| – | – | ﹤0.01% | 2520 |
|
|
2021
Q2 | $25K | Hold |
1,653
| – | – | ﹤0.01% | 2630 |
|
|
2021
Q1 | $32K | Hold |
1,653
| – | – | ﹤0.01% | 2344 |
|
|
2020
Q4 | $30K | Hold |
1,653
| – | – | ﹤0.01% | 2283 |
|
|
2020
Q3 | $32K | Hold |
1,653
| – | – | ﹤0.01% | 2124 |
|
|
2020
Q2 | $43K | Hold |
1,653
| – | – | ﹤0.01% | 1928 |
|
|
2020
Q1 | $29K | Hold |
1,653
| – | – | ﹤0.01% | 1976 |
|
|
2019
Q4 | $55K | Hold |
1,653
| – | – | ﹤0.01% | 1868 |
|
|
2019
Q3 | $39K | Hold |
1,653
| – | – | ﹤0.01% | 2025 |
|
|
2019
Q2 | $59K | Buy |
+1,653
| New | +$59K | ﹤0.01% | 1831 |
|